207 related articles for article (PubMed ID: 22090255)
1. Recombinant human IGF-1 (insulin-like growth factor) therapy: where do we stand today?
Balhara B; Misra M; Levitsky LL
Indian J Pediatr; 2012 Feb; 79(2):244-9. PubMed ID: 22090255
[TBL] [Abstract][Full Text] [Related]
2. The role of recombinant human insulin-like growth factor-I in treating children with short stature.
Collett-Solberg PF; Misra M;
J Clin Endocrinol Metab; 2008 Jan; 93(1):10-8. PubMed ID: 18165284
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human insulin-like growth factor-I therapy for children with growth disorders.
Richmond EJ; Rogol AD
Adv Ther; 2008 Dec; 25(12):1276-87. PubMed ID: 19066756
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human insulin-like growth factor I (IGF-I): risks and benefits of normalizing blood IGF-I concentrations.
Clark RG
Horm Res; 2004; 62 Suppl 1():93-100. PubMed ID: 15761240
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA;
Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099
[TBL] [Abstract][Full Text] [Related]
6. Recombinant insulin-like growth factor-1 as a therapy for IGF-1 deficiency in renal failure.
Clark RG
Pediatr Nephrol; 2005 Mar; 20(3):290-4. PubMed ID: 15682316
[TBL] [Abstract][Full Text] [Related]
7. Mecasermin (recombinant human insulin-like growth factor I).
Rosenbloom AL
Adv Ther; 2009 Jan; 26(1):40-54. PubMed ID: 19198769
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-I (rhIGF-I) therapy of short stature.
Rosenbloom AL
J Pediatr Endocrinol Metab; 2008 Apr; 21(4):301-15. PubMed ID: 18556960
[TBL] [Abstract][Full Text] [Related]
9. Recombinant insulin-like growth factor (IGF)-I treatment in short children with low IGF-I levels: first-year results from a randomized clinical trial.
Midyett LK; Rogol AD; Van Meter QL; Frane J; Bright GM;
J Clin Endocrinol Metab; 2010 Feb; 95(2):611-9. PubMed ID: 19880790
[TBL] [Abstract][Full Text] [Related]
10. A two year observation of the process of applying recombinant IGF-1 to treat short stature in children with primary IGF-1 deficiency -- case reports of 3 patients.
Petriczko E; Wikiera B; Horodnicka-Józwa A; Marcinkiewicz K; Szmit-Domagalska J; Kędzia A; Durzyńska J; Broniarczyk J; Gabryelczyk B; Noczyńska A; Walczak M
Pediatr Endocrinol Diabetes Metab; 2011; 17(4):233-8. PubMed ID: 22248785
[TBL] [Abstract][Full Text] [Related]
11. Treatment of severe primary IGF-1 deficiency using rhIGF-1 preparation - first three years of Polish experience.
Petriczko E; Jackowski T; Horodnicka-Józwa A; Wikiera B; Noczyńska A; Korpal-Szczyrska M; Birkholz-Walerzak D; Małecka-Tendera E; Kalina-Fraska B; Kalina M; Barg E; Beń-Skowronek I; Szewczyk L; Hilczer M; Smyczyńska J; Stawerska R; Lewiński A; Ziora K; Bossowski A; Pietrewicz E; Pyrżak B; Kędzia A; Szalecki M; Kilian A; Walczak M
Endokrynol Pol; 2019; 70(1):20-27. PubMed ID: 30351442
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Human Insulin-Like Growth Factor-1 Treatment of Severe Growth Failure in Three Siblings with STAT5B Deficiency.
Muthuvel G; Al Remeithi SS; Foley C; Dauber A; Hwa V; Backeljauw P
Horm Res Paediatr; 2024; 97(2):195-202. PubMed ID: 37586336
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human insulin-like growth factor-1 treatment: ready for primetime.
Bright GM; Mendoza JR; Rosenfeld RG
Endocrinol Metab Clin North Am; 2009 Sep; 38(3):625-38. PubMed ID: 19717008
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity.
Chernausek SD; Backeljauw PF; Frane J; Kuntze J; Underwood LE;
J Clin Endocrinol Metab; 2007 Mar; 92(3):902-10. PubMed ID: 17192294
[TBL] [Abstract][Full Text] [Related]
15. A rationale for the treatment of short stature in children with the combination of recombinant human growth hormone (rhGH) and recombinant human insulin-like growth factor-I (rhIGF-I).
Bright GM; Fierro-Renoy JF
Growth Horm IGF Res; 2020 Jun; 52():101318. PubMed ID: 32252003
[TBL] [Abstract][Full Text] [Related]
16. Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
Drugs R D; 2005; 6(2):120-7. PubMed ID: 15777106
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options.
Kemp SF
BioDrugs; 2009; 23(3):155-63. PubMed ID: 19627167
[TBL] [Abstract][Full Text] [Related]
18. Impaired growth in Rabson-Mendenhall syndrome: lack of effect of growth hormone and insulin-like growth factor-I.
Longo N; Singh R; Griffin LD; Langley SD; Parks JS; Elsas LJ
J Clin Endocrinol Metab; 1994 Sep; 79(3):799-805. PubMed ID: 8077364
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Safety and Efficacy of Growth Hormone Therapy by IGF-1 Z Score in Children with Short Stature.
Liu HJ; Wang LH; Chen L
Adv Ther; 2019 Sep; 36(9):2374-2383. PubMed ID: 31301056
[TBL] [Abstract][Full Text] [Related]
20. Recombinant IGF-I: Past, present and future.
Bright GM
Growth Horm IGF Res; 2016 Jun; 28():62-5. PubMed ID: 26822565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
